Microbiotica

Precision Microbiome Medicines

Founded 2016 · $68.2M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$68.2M
Last Round
$68.2M Series BMar 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Microbiotica is a clinical-stage biopharmaceutical company that develops precision live biotherapeutic products for immuno-oncology and inflammatory bowel disease. Its proprietary microbiome profiling platform uses clinical data to identify bacterial strains linked to patient benefit, informing oral live bacterial medicines such as MB097 for melanoma checkpoint-inhibitor combinations and MB310 for ulcerative colitis. Spun out of Trevor Lawley's laboratory at the Wellcome Sanger Institute, the company operates from purpose-designed facilities at Chesterford Research Park in Cambridge, United Kingdom.

Summary

Microbiotica is a Biotech company, founded in 2016. It has raised $68.2M in total across 1 round, most recently a $68.2M Series B round in Mar 2022.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2022
$68.2M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Microbiotica on Indexed.vc
<a href="https://indexed.vc/companies/microbiotica"><img src="https://indexed.vc/api/badge/company/microbiotica" alt="Microbiotica on Indexed.vc" width="260" height="76" /></a>